David Wright
Family Medicine · Austin, TXNPI 1487677282
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $84,295 of the $123,859 with a category attached, or 68.1%. Gilead accounts for 70.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $37,770 and has fallen 55.4% since, to $16,848 in 2025. Among family medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 277 payments — averaging $447.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$87K
- Merck$15K
- Janssen Products, LP$13K
- Viiv Healthcare Company$5K
- Theratechnologies Inc.$3K
- EMD Serono, Inc.$153
- plus $473 from 6 others
What the payments were for
- Consulting fees$23,30019%
- Speaking & faculty fees$84,29568%
- Travel & lodging$11,0469%
- Food & beverage$5,1794%
- Education$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 114 | $87,430 |
| Merck | 46 | $15,110 |
| Janssen Products, LP | 12 | $12,892 |
| Viiv Healthcare Company | 79 | $5,219 |
| Theratechnologies Inc. | 5 | $2,580 |
| EMD Serono, Inc. | 5 | $153 |
| Johnson & Johnson(2 entities) | 11 | $148 |
| Inspire Medical Systems, Inc. | 1 | $146 |
| Sanofi | 1 | $124 |
| AbbVie | 1 | $21 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$123,859 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 137 | $521,905 |
| JulucaDolutegravir/Rilpivirine | 124 | $439,498 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 68 | $310,944 |
| TivicayDolutegravir Sodium | 80 | $308,124 |
| DescovyEmtricitabine/Tenofov Alafenam | 121 | $292,456 |
| DovatoDolutegravir Sodium/Lamivudine | 91 | $282,508 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 48 | $168,253 |
| PrezcobixDarunavir/Cobicistat | 67 | $160,201 |
| DelstrigoDoravirine/Lamivu/Tenofov Diso | 51 | $128,753 |
| Naloxone Hcl | 1,666 | $105,132 |
| IsentressRaltegravir Potassium | 16 | $45,594 |
| PifeltroDoravirine | 26 | $41,877 |
| EdurantRilpivirine Hcl | 23 | $33,550 |
| Maraviroc | 24 | $24,967 |
| OzempicSemaglutide | 26 | $23,994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyJuluca, Tivicay, Dovato | $5,219 | $1,030,130295 claims |
| GileadBiktarvy, Descovy | $87,430 | $814,361258 claims |
| Janssen Products, LPSymtuza | $12,892 | $310,94468 claims |
| MerckDelstrigo, Isentress, Pifeltro, Belsomra | $15,110 | $221,024105 claims |
| Johnson & JohnsonPrezcobix, Xarelto | $148 | $166,60479 claims |
| Janssen Scientific Affairs, LLCEdurant | $20 | $33,55023 claims |
| AbbVieLinzess | $21 | $10,45416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Austin
- Cynthia BrinsonAustin$402K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.